Graham Capital Management L.P. Purchases New Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Graham Capital Management L.P. purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 55,710 shares of the company's stock, valued at approximately $1,292,000.

Other hedge funds have also made changes to their positions in the company. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health during the fourth quarter valued at approximately $26,000. UMB Bank n.a. raised its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC raised its holdings in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after acquiring an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its holdings in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after acquiring an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Option Care Health in the fourth quarter valued at approximately $47,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Insider Activity

In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.64% of the company's stock.

Option Care Health Stock Up 2.3%

NASDAQ OPCH traded up $0.74 during trading on Friday, reaching $33.23. 1,396,952 shares of the company's stock were exchanged, compared to its average volume of 1,856,304. The stock has a market cap of $5.44 billion, a P/E ratio of 27.92, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a 50 day moving average price of $33.07 and a two-hundred day moving average price of $28.98. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same period in the previous year, the business earned $0.26 EPS. Option Care Health's revenue for the quarter was up 16.3% on a year-over-year basis. On average, equities research analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analysts Set New Price Targets

OPCH has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, JMP Securities reissued a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.